Lonza Group AG (LONN.SW)

Swiss - Swiss Delayed Price. Currency in CHF

Add to watchlist

480.30

-0.80

(-0.17%)

At close: 05:30PM CEST

Loading interactive chart...

GuruFocus.com
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
GuruFocus.com
Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
PR Newswire
NeuroSense Announces First Quarter 2024 Business Update
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.